Human Resources

Cesca Therapeutics Appoints Healthcare Investment Banking Veteran Joe E. Balagot as Senior Vice President of Corporate Development

November 22, 2017

RANCHO CORDOVA, Calif., Nov. 22, 2017 (GLOBE NEWSWIRE) — Cesca Therapeutics Inc. (NASDAQ:KOOL), a market leader in automated cell processing and point-of-care, autologous cell-based therapies, today announced the appointment of healthcare investment banking veteran Joe Balagot to the newly-created position of senior vice president of corporate development, effective immediately. Mr. Balagot, who will report to […]

AVEO Announces Appointment of Nikhil Mehta, Ph.D., as Senior Vice President of Regulatory and Quality Assurance

November 20, 2017

CAMBRIDGE, Mass.–(BUSINESS WIRE)–AVEO Oncology (NASDAQ: AVEO) today announced the appointment of Nikhil Mehta, Ph.D., as Senior Vice President of Regulatory and Quality Assurance, effective November 20, 2017. In this role, Dr. Mehta will oversee all aspects of regulatory, quality and technical operations for the company’s portfolio. Dr. Mehta brings to AVEO more than 25 years […]

Circle Pharma Announces Appointment of David Spellmeyer, PhD, as Chief Scientific Officer

November 20, 2017

SOUTH SAN FRANCISCO, Calif.–(BUSINESS WIRE)–Circle Pharma, Inc., a developer of macrocycle therapeutics, today announced that David Spellmeyer, PhD, has been appointed as its chief scientific officer.   “His deep experience in rational drug design and discovery is an excellent fit for Circle as we extend our platform for macrocycle discovery and advance our therapeutic pipeline […]

Gamida Cell Appoints Julian Adams, Ph.D., Chairman and Chief Executive Officer

November 20, 2017

JERUSELUM, Israel and CAMBRIDGE, Mass., November 20, 2017 – Gamida Cell, a leading cellular and immune therapeutics company, today announced the appointment of Julian Adams, Ph.D., as chairman and chief executive officer. Dr. Adams brings more than 30 years of drug discovery and development experience to his new role as CEO of Gamida Cell. He […]

Pertinax Pharma appoints Nigel Brooksby as Chairman Former chairman of Sanofi to help drive the commercialization of Pertinax®

November 20, 2017

14 November 2017: Pertinax Pharma announces that Nigel Brooksby has been appointed as chairman of the company. His chief responsibilities will be to assist in corporate, strategic and business development moves into its commercialisation phase following the launch last month of Pertinax®. This unique technology which enables controlled and sustained release of the antimicrobial, chlorhexidine […]

Turnstone Biologics Appoints Dr. Mike Burgess as President of Research and Development

November 15, 2017

OTTAWA, Ontario & NEW YORK–(BUSINESS WIRE)–Turnstone Biologics, a clinical-stage immuno-oncology company, today announced the appointment of Mike Burgess, MBChB, Ph.D., as president of research and development. Dr. Burgess joins from Bristol-Myers Squibb, where he was senior vice president of development across multiple therapeutic areas. At Turnstone Biologics, he will lead all functions in the R&D […]

PAREXEL Expands Global Regulatory Services with Addition of Senior Executives from FDA and Oncology Industry

November 15, 2017

BOSTON–(BUSINESS WIRE)–PAREXEL, a leading global biopharmaceutical services provider, today announced the appointment of three former senior regulatory consulting executives from the U.S. Food and Drug Administration (FDA) and Oncology industry positions. The new hires are part of PAREXEL’s Global Integrated Product Development and Compliance team and will be focused on helping PAREXEL clients deliver commercially […]

Trump Expected to Name ex-Lilly Executive Azar as HHS Secretary

November 9, 2017

(Bloomberg)—President Donald Trump is expected to name former drug industry executive Alex Azar to lead the Department of Health and Human Services, according to people familiar with the matter. Azar, who worked at Eli Lilly & Co., would be the administration’s point person for running—or dismantling—Obamacare, the health program enacted by Trump’s predecessor that insures […]

Medivir Appoints Erik Björk as Chief Financial Officer

November 3, 2017

HUDDINGE, Sweden, Nov. 3, 2017 /PRNewswire/ — Medivir AB (Nasdaq Stockholm: MVIR) announces today that it has appointed Erik Björk as Chief Financial Officer effective January 3, 2018.   Erik Björk will join Medivir from AstraZeneca where he has been the CFO for Sweden Operations. He has extensive experience as a global financial leader having […]

Selecta Biosciences Announces Important Additions to Senior Leadership Team

October 26, 2017

WATERTOWN, Mass., Oct. 26, 2017 (GLOBE NEWSWIRE) — Selecta Biosciences, Inc. (NASDAQ:SELB), a clinical-stage biopharmaceutical company focused on unlocking the full potential of biologic therapies by avoiding unwanted immune responses, today announced two additions to its management team with the appointment of John Leaman, M.D., as the company’s new Chief Financial Officer and Head of […]

Albumedix Establishes Scientific Advisory Board

October 22, 2017

Press Release: Copenhagen, Denmark: Albumedix has announced the formation of a Scientific Advisory Board (SAB) to provide governance, oversight and advice to Albumedix’s R&D organization as it builds and develops its pipeline of proprietary and differentiated drugs. The SAB, chaired by Dr. John Westwick, includes distinguished individuals with deep relevant experience in science and pharmaceutical […]

Cellect Appoints Dr. Ronit Bakimer-Kleiner as Chief Development Officer

October 20, 2017

TEL AVIV, Israel, October 19, 2017 /PRNewswire/ —   Cellect Biotechnology Ltd. (Nasdaq: APOP), a developer of stem cells selection technology, announced today that it has nominated Dr. Ronit Bakimer-Kleiner as Chief Development Officer replacing Dr. Yaron Pereg.   Dr. Bakimer-Kleiner has over twenty years of experience as a scientist and executive manager in the […]

Bayer Appoints Jennifer Brendel to Vice President, Head of U.S. Consumer Health Communications

October 20, 2017

WHIPPANY, N.J., Oct. 19, 2017 /PRNewswire/ — Bayer is proud to announce today the appointment of Jennifer Brendel to Vice President of Communications for the company’s Consumer Health Division in the United States.   Brendel, who spent the last 15 months leading Bayer’s Pharmaceutical Product Communications, will be responsible for developing and executing external and […]

Pernix Therapeutics Announces Planned Departure of Chief Financial Officer

October 18, 2017

MORRISTOWN, N.J., Oct. 17, 2017 (GLOBE NEWSWIRE) — Pernix Therapeutics Holdings, Inc. (NASDAQ:PTX) (“Pernix” or the “Company”), a specialty pharmaceutical company, today announced that Graham Miao, Ph.D., President and Chief Financial Officer (CFO), will leave the Company at the end of the year in order to pursue other opportunities. Pernix will immediately begin a search […]

Menlo Therapeutics Expands its Management Team

October 18, 2017

REDWOOD CITY, Calif., Oct. 17, 2017 /PRNewswire/ — Menlo Therapeutics Inc., a late stage biopharmaceutical company, is developing a neurokinin 1 (NK‐1) receptor antagonist (serlopitant) for the treatment of pruritus (itch) associated with various underlying conditions, and for the treatment of refractory chronic cough. The company, which continues to advance serlopitant into later stages of […]

Bayer Appoints Brenda L. Raphael Senior Vice President and General Manager of Therapeutics Business Unit for Consumer Health

October 18, 2017

WHIPPANY, N.J., Oct. 17, 2017 /PRNewswire/ — Bayer today announced the appointment of Brenda L. Raphael as Senior Vice President and General Manager of the Therapeutics Business Unit of Consumer Health Commercial Operations North America, effective October 30, 2017.   “Brenda has more than 20 years of experience in leading successful billion-dollar, consumer-focused brands,” said […]

Gilead Sciences Announces Promotion of Alessandro Riva to Executive Vice President, Oncology Therapeutics

October 18, 2017

FOSTER CITY, Calif.–(BUSINESS WIRE)–Gilead Sciences, Inc. (Nasdaq: GILD) announced today the promotion of Alessandro Riva, MD, to Executive Vice President, Oncology Therapeutics, with responsibility for Gilead’s hematology and oncology programs, including cell therapy research and development. Dr. Riva will become a member of Gilead’s senior leadership team.   Dr. Riva joined Gilead in January 2017 […]

Clinipace Worldwide Co-founder & CEO Jeff Williams to Resign as CEO

October 17, 2017

MORRISVILLE, N.C., Oct. 17, 2017 (GLOBE NEWSWIRE) — Jeff Williams, Co-founder, President, and CEO of Clinipace Worldwide, a global full-service clinical research organization (CRO) that he founded 14 years ago, has elected to move into an expanded advisory role with the company’s Board of Directors. He will be handing over his responsibilities to Jason Monteleone, […]

Boston Biomedical, Inc. Appoints Edgar Braendle, M.D., Ph.D., as Head of Research and Development and Chief Medical Officer

October 17, 2017

CAMBRIDGE, Mass., Oct. 16, 2017 /PRNewswire/ — Boston Biomedical, Inc., an industry leader in the development of next-generation cancer therapeutics, today announced the appointment of Edgar Braendle, M.D., Ph.D., to Executive Vice President, Head of Research and Development and Chief Medical Officer. Dr. Braendle will lead the company’s discovery research and clinical strategies.   “I […]

Silicon Therapeutics Appoints Dr. Christopher Winter as Chief of R&D

October 17, 2017

BOSTON–(BUSINESS WIRE)–Silicon Therapeutics, an integrated physics-based drug discovery company creating novel small molecule therapeutics for diseases with challenging protein targets, announced today the appointment of Dr. Christopher Winter as Chief of R&D. Dr. Winter joins Silicon Therapeutics from Sanofi, where he led the company’s US Oncology Research as Site Lead and Research Cluster Head on […]

Eleven Biotherapeutics Appoints Richard Fitzgerald as Interim Chief Financial Officer

October 16, 2017

CAMBRIDGE, Mass.–(BUSINESS WIRE)–Eleven Biotherapeutics, Inc. (NASDAQ:EBIO), a late-stage clinical oncology company advancing novel product candidates based on its Targeted Protein Therapeutics (TPTs) platform, today announced the appointment of Richard F. Fitzgerald as Interim Chief Financial Officer effective October 20, 2017. John McCabe, who currently holds that position, will be stepping down.   “I look forward […]

IO Biotech Appoints Dr. Eva Ehrnrooth as Chief Medical Officer

October 13, 2017

COPENHAGEN, Denmark, Oct. 12, 2017 /PRNewswire/ — IO Biotech, a private company developing novel immuno-oncology therapies targeting immune checkpoint inhibitory targets to treat cancer, today announced the appointment of Eva Ehrnrooth, M.D., Ph.D., to the position of chief medical officer. Dr. Ehrnrooth, a board-certified oncologist, joins the company from Boehringer Ingelheim and brings more than […]

BioAegis Therapeutics Hires Dr. Mark J. DiNubile as Chief Medical Officer to Spearhead Forthcoming Phase 2 Clinical Trials in Community-Acquired Pneumonia

October 13, 2017

BOSTON and MORRISTOWN, N.J., Oct. 13, 2017 (GLOBE NEWSWIRE) — BioAegis Therapeutics Inc., a privately held biotechnology company exploiting the role of plasma gelsolin (pGSN) in augmenting innate immunity announced that Mark J. DiNubile has joined the organization as Chief Medical Officer. Dr. DiNubile brings to BioAegis the rare combination of clinical and research expertise […]

Dr. Bastian Dehmel Appointed CMO of OxThera

October 13, 2017

STOCKHOLM, October 13, 2017 /PRNewswire/ —   OxThera AB, a Stockholm-based privately-held biopharmaceutical company today announced the appointment of Dr. Bastian Dehmel as their new Chief Medical Officer.   OxThera is developing a novel treatment, Oxabact, for Primary Hyperoxaluria (PH), a severe and often fatal disease in children, and where there are currently no available […]

Trevi Therapeutics Hires Dr. Helena Brett-Smith as Chief Development Officer

October 12, 2017

NEW HAVEN, Conn.–(BUSINESS WIRE)–Trevi Therapeutics, Inc. (“Trevi” or the “Company”), a late-stage clinical development company focused on developing Nalbuphine® ER for chronic pruritus (itch), today announced that it has hired Helena Brett-Smith, M.D., as Chief Development Officer.   Trevi Therapeutics welcomes Dr. Helena Brett-Smith as Chief Development Officer. #NalbuphineER #Pruritus Tweet this Dr. Brett-Smith has […]

Pieris Pharmaceuticals Appoints Ingmar Bruns, M.D., Ph.D., as Vice President of Clinical Development

October 12, 2017

BOSTON, MA–(Marketwired – October 12, 2017) – Pieris Pharmaceuticals, Inc. (NASDAQ: PIRS), a clinical-stage biotechnology company advancing novel biotherapeutics through its proprietary Anticalin® technology platform for cancer, respiratory and other diseases, announced that it has appointed Ingmar Bruns, M.D., Ph.D., as Vice President of Clinical Development, effective today. Dr. Bruns is an accomplished physician and […]

SutroVax Appoints Veteran Vaccine Experts to Executive Team

October 12, 2017

FOSTER CITY, Calif., Oct. 11, 2017 /PRNewswire/ — SutroVax, a biopharmaceutical company dedicated to the delivery of best-in-class conjugate vaccines and novel complex antigen-based vaccines to prevent serious infectious diseases, today announced that it has appointed additional biotechnology and pharmaceutical industry veterans to its executive team, including Alan Kimura, M.D. Ph.D., as Chief Medical Officer, […]

TCR2 Therapeutics Appoints Leading Cell Therapy Expert as Chief Medical Officer

October 12, 2017

CAMBRIDGE, Mass., Oct. 11, 2017 /PRNewswire/ — TCR2 Therapeutics Inc., today announced three new management appointments as the company advances its TRuC™-T cell programs toward the clinic to address solid tumors. Alfonso Quintás Cardama, MD, was named as the company’s first Chief Medical Officer. In this role, he will be responsible for clinical and regulatory […]

Inception Companies Hires Agency Titan Matt Giegerich to Serve as New CEO for its Two Lead Businesses

October 12, 2017

FAIRFIELD, N.J., Oct. 10, 2017 /PRNewswire/ — The Inception Companies announce the appointment of Matt Giegerich, longtime CEO of WPP’s Ogilvy CommonHealth, to serve as CEO for Inception’s two largest business units. During his 25-year tenure at Ogilvy CommonHealth Matt helped shape and grow the company to become one of the largest healthcare advertising agency […]

FEEDBACK